← Back to Search

Primary Care Linkage for Addiction Treatment (Linkage Trial)

N/A
Waitlist Available
Led By Constance M Weisner, DrPH, LCSW
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Research participants will be adult patients at the Kaiser Permanente San Francisco Chemical Dependency Recovery Program, who have completed 2 weeks of treatment.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 and 24 months post baseline
Awards & highlights

Summary

This trial improves drug abuse treatment by connecting specialty drug treatment and primary health care.

Who is the study for?
This trial is for adults at the Kaiser Permanente San Francisco Chemical Dependency Recovery Program who have finished at least 2 weeks of treatment for substance use disorders, including addiction and alcoholism. Those with dementia, mental retardation, or current psychosis or suicidal tendencies cannot participate.
What is being tested?
The study tests a 'linkage patient activation intervention' designed to improve connections between specialty drug treatment and primary health care as part of enhancing overall drug abuse treatment.
What are the potential side effects?
Since this trial involves a linkage intervention rather than medication, it does not directly list side effects like drug trials do. However, participants may experience stress or anxiety related to changes in their care routine.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am an adult who has completed 2 weeks at Kaiser's San Francisco addiction recovery program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 and 24 months post baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 and 24 months post baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Substance use and mental health outcomes
patient activation measure
patient engagement in health care (including patient portal use, familiarity and satisfaction with Primary Care physician, and CD treatment length of stay)
Secondary study objectives
Health care utilization and cost
Substance use and mental health outcomes at 12 and 24 months
patient activation measure at 12 and 24 months
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Linkage patient activation interventionExperimental Treatment1 Intervention
Usual Care with the exception that the six 45-min Linkage patient activation education groups replaced the six 45-min Usual Care medical education groups, plus a linkage phone call (and/or a facilitated email) with the patient, clinician, and Primary Care physician.
Group II: Usual CareActive Control1 Intervention
Usual CD treatment, including therapy groups and individual counseling sessions, and six 45-min medical education groups. Physician appointments, pharmacotherapy, and SUD medications were be available as needed.

Find a Location

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor
551 Previous Clinical Trials
27,690,456 Total Patients Enrolled
Kaiser Foundation Research InstituteOTHER
27 Previous Clinical Trials
20,792 Total Patients Enrolled
Constance M Weisner, DrPH, LCSWPrincipal InvestigatorKaiser Permanente

Media Library

Linkage patient activation intervention Clinical Trial Eligibility Overview. Trial Name: NCT01621711 — N/A
Substance Addiction Research Study Groups: Usual Care, Linkage patient activation intervention
Substance Addiction Clinical Trial 2023: Linkage patient activation intervention Highlights & Side Effects. Trial Name: NCT01621711 — N/A
Linkage patient activation intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT01621711 — N/A
~43 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top